These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17171188)

  • 1. Ertapenem for diabetic foot infections.
    Rogers LC; Bevilacqua NJ; Armstrong DG
    Drugs Today (Barc); 2006 Nov; 42(11):695-701. PubMed ID: 17171188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microbiology of diabetic foot infections: role of ertapenem].
    Lima AL; Oliveira PR; Carvalho VC; Peixoto de Miranda EJ
    Drugs Today (Barc); 2013 May; 49 Suppl A():1-20. PubMed ID: 23724414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial.
    Lipsky BA; Armstrong DG; Citron DM; Tice AD; Morgenstern DE; Abramson MA
    Lancet; 2005 Nov; 366(9498):1695-703. PubMed ID: 16291062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of diabetic foot infections: focus on ertapenem.
    Edmonds M
    Vasc Health Risk Manag; 2009; 5():949-63. PubMed ID: 19997576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis.
    Lauf L; Ozsvár Z; Mitha I; Regöly-Mérei J; Embil JM; Cooper A; Sabol MB; Castaing N; Dartois N; Yan J; Dukart G; Maroko R
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):469-80. PubMed ID: 24439136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial.
    Xu ZR; Ran XW; Xian Y; Yan XD; Yuan GY; Mu SM; Shen JF; Zhang BS; Gan WJ; Wang J
    J Antimicrob Chemother; 2016 Jun; 71(6):1688-96. PubMed ID: 26888908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inpatient Management of Diabetic Foot Infections: A Review of the Guidelines for Hospitalists.
    Thurber EG; Kisuule F; Humbyrd C; Townsend J
    J Hosp Med; 2017 Dec; 12(12):994-1000. PubMed ID: 29236099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative costs of ertapenem and cefotetan as prophylaxis for elective colorectal surgery.
    Wilson SE; Turpin RS; Kumar RN; Itani KM; Jensen EH; Pellissier JM; Abramson MA
    Surg Infect (Larchmt); 2008 Jun; 9(3):349-56. PubMed ID: 18570576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic foot infections: diagnosis and management.
    Weigelt JA
    Surg Infect (Larchmt); 2010 Jun; 11(3):295-8. PubMed ID: 20553107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of diabetic foot infections.
    Bader MS; Brooks A
    Postgrad Med; 2012 Mar; 124(2):102-13. PubMed ID: 22437220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections.
    Sauermann R; Burian B; Burian A; Jäger W; Höferl M; Stella A; Theurer S; Riedl M; Zeitlinger M
    J Antimicrob Chemother; 2013 Apr; 68(4):895-9. PubMed ID: 23212112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ertapenem-associated psychosis and encephalopathy.
    Oo Y; Packham D; Yau W; Munckhof WJ
    Intern Med J; 2014 Aug; 44(8):817-9. PubMed ID: 25081048
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of ertapenem for the treatment of lower extremity infections.
    Nielsen MD; Mendicino RW; Catanzariti AR
    J Foot Ankle Surg; 2009; 48(2):135-41. PubMed ID: 19232964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial.
    Lipsky BA; Sheehan P; Armstrong DG; Tice AD; Polis AB; Abramson MA
    Int Wound J; 2007 Mar; 4(1):30-8. PubMed ID: 17425547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of diabetic foot infections.
    Lipsky BA; Berendt AR; Deery HG; Embil JM; Joseph WS; Karchmer AW; LeFrock JL; Lew DP; Mader JT; Norden C; Tan JS;
    Clin Infect Dis; 2004 Oct; 39(7):885-910. PubMed ID: 15472838
    [No Abstract]   [Full Text] [Related]  

  • 16. Executive summary: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.
    Lipsky BA; Berendt AR; Cornia PB; Pile JC; Peters EJ; Armstrong DG; Deery HG; Embil JM; Joseph WS; Karchmer AW; Pinzur MS; Senneville E;
    Clin Infect Dis; 2012 Jun; 54(12):1679-84. PubMed ID: 22619239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.
    Lipsky BA; Berendt AR; Cornia PB; Pile JC; Peters EJ; Armstrong DG; Deery HG; Embil JM; Joseph WS; Karchmer AW; Pinzur MS; Senneville E;
    Clin Infect Dis; 2012 Jun; 54(12):e132-73. PubMed ID: 22619242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of association between use of ertapenem and change in antipseudomonal carbapenem susceptibility rates in 25 hospitals.
    Eagye KJ; Nicolau DP
    Infect Control Hosp Epidemiol; 2010 May; 31(5):485-90. PubMed ID: 20334550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A report from the international consensus on diagnosing and treating the infected diabetic foot.
    Lipsky BA;
    Diabetes Metab Res Rev; 2004; 20 Suppl 1():S68-77. PubMed ID: 15150818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapies for diabetic foot infections and osteomyelitis.
    Sagray BA; Malhotra S; Steinberg JS
    Clin Podiatr Med Surg; 2014 Jan; 31(1):57-70. PubMed ID: 24296018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.